NCT00001426View on ClinicalTrials.gov

A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 3, 1995

Primary Completion Date

October 15, 2007

Study Completion Date

November 7, 2013

Conditions
Ovarian Neoplasm
Interventions
DRUG

Cyclophosphamide

DRUG

Paclitaxel

DRUG

Cisplatin

DRUG

G-CSF

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH